Department of Orthopaedic Surgery, University of South Alabama, Mobile, AL, USA.
J Sports Sci Med. 2009 Mar 1;8(1):37-44. eCollection 2009.
The use of oral corticosteroid (OCS) drugs is advocated because of their potent anti-inflammatory effects. They also possess many potential adverse effects. No study has assessed physician prescribing practices of OCS therapy in high school (HS) or college (COL) athletes. This paper reports the prescribing patterns of sports medicine physicians who used short-term OCS therapy and to describe associated complications in HS and COL athletes within a 24- month period. An internet link to a descriptive epidemiology survey was included in an e-mail to all members of the Arthroscopy Association of North America and the American Orthopaedic Society for Sports Medicine. Descriptive statistics and correlation analysis were used to examine responses. Total response rate was 32% (615/1,928). Sixty-six percent of the physicians indicated prescribing OCS to both groups of athletes, while 29% reported prescribing OCS to COL athletes and 5% to HS athletes for musculoskeletal injuries. Physicians who prescribed multiple OCS regimens to the same athlete within the same season (P = 0.01) and physicians who prescribed OCS to the skeletally immature athlete (P = 0.009) reported more complications than other physicians. Among the 412 physicians who did not prescribe OCS in the treatment of athletic induced musculoskeletal injury, 251 (61%) cited a risk of developing medical complications as the primary reason for avoiding use. The reported number of medical complications was low with no cases of avascular necrosis reported for the 2-year recall period. Orthopaedic surgeons who treated athletic induced musculoskeletal injuries with a short-term course of oral corticosteroids reported that high school and college athletes benefited with few medical complications. Key pointsThirty-four percent of orthopaedic sports medicine physicians we surveyed reported prescribing a short-term course of oral corticosteroids for the treatment of an athletic-related musculoskeletal injury within the previous 24 months of answering the survey.The orthopaedic surgeons who treated athletic induced musculoskeletal injuries with a short-term course of OCS reported the high school and college athletes benefited from OCS treatment with few medical complications.Short-term oral corticosteroid use in multiple regimens in the same athlete and in the skeletally immature athlete may pose an increased risk of medical complication.
使用口服皮质类固醇（OCS）药物是因为它们具有强大的抗炎作用。它们也有许多潜在的不良反应。目前还没有研究评估高中（HS）或大学（COL）运动员的医生对 OCS 治疗的处方实践。本文报告了在 24 个月的时间内，使用短期 OCS 治疗的运动医学医生的处方模式，并描述了 HS 和 COL 运动员相关的并发症。一项描述性流行病学调查的互联网链接被包含在一封电子邮件中，发给了北美关节镜协会和美国运动医学骨科协会的所有成员。使用描述性统计和相关分析来检查回复。总回复率为 32%（615/1,928）。66%的医生表示给两组运动员都开了 OCS，而 29%的医生表示给 COL 运动员开了 OCS，5%的医生给 HS 运动员开了 OCS 用于治疗肌肉骨骼损伤。同一赛季同一运动员使用多种 OCS 方案的医生（P=0.01）和给骨骼未成熟运动员开 OCS 的医生（P=0.009）报告的并发症比其他医生多。在 412 名未在治疗运动引起的肌肉骨骼损伤中使用 OCS 的医生中，251 名（61%）表示避免使用的主要原因是担心出现医疗并发症。在 2 年的随访期间，报告的医疗并发症数量很少，没有发生股骨头坏死的病例。使用短期口服皮质类固醇治疗运动引起的肌肉骨骼损伤的骨科医生报告说，高中和大学运动员受益于很少的医疗并发症。要点接受调查的 34%的骨科运动医学医生报告说，在回答调查前 24 个月内，他们曾为治疗与运动相关的肌肉骨骼损伤开具短期口服皮质类固醇处方。使用短期 OCS 治疗的骨科医生报告说，高中和大学运动员受益于 OCS 治疗，并发症很少。同一运动员和骨骼未成熟运动员中使用多种方案的短期口服皮质类固醇可能会增加医疗并发症的风险。
